Register for email alerts and news feeds:
This journal | BMJ Group
rss
Published Online First: 9 August 2005. doi:10.1136/gut.2005.076752
Gut 2006;55:165-171
Copyright © 2006 BMJ Publishing Group Ltd & British Society of Gastroenterology.

STOMACH

Gastroprotective effects of oral nucleotide administration

A Belo, T Marchbank, A Fitzgerald, S Ghosh, R J Playford

Department of Gastroenterology, Imperial College, Hammersmith Hospital Campus, London, UK

Correspondence to:
Dr T Marchbank
Department of Gastroenterology, Imperial College Faculty of Medicine, Hammersmith Hospital, Ducane Rd, London W12 0NN, UK; t.marchbank{at}imperial.ac.uk

Background and aims: Nucleotides form the building blocks of DNA and are marketed as dietary supplements, alone or in combination with other ingredients, to promote general health. However, there has been only limited scientific study regarding the true biological activity of orally administered nucleotides. We therefore tested their efficacy in a variety of models of epithelial injury and repair.

Methods: Effects on proliferation ([3H] thymidine incorporation) and restitution (cell migration of wounded monolayers) were analysed using HT29 and IEC6 cells. The ability of a nucleotide mixture to influence gastric injury when administered orally and subcutaneously was analysed using a rat indomethacin (20 mg/kg) restraint model.

Results: In both cell lines, cell migration was increased by approximately twofold when added at 1 mg/ml (p<0.01); synergistic responses were seen when a mixture of nucleotides was used. Cell proliferation was stimulated by adenosine monophosphate (AMP) in HT29, but not in IEC6, cells. Gastric injury was reduced by approximately 60% when gavaged at 4–16 mg/ml (p<0.05), concentrations similar to those likely to be found in consumers taking nucleotide supplements. Systemic administration of nucleotides was unhelpful.

Conclusions: Nucleotides possess biological activity when analysed in a variety of models of injury and repair and could provide a novel inexpensive approach for the prevention and treatment of the injurious effects of non steroidal anti-inflammatory drugs and other ulcerative conditions of the bowel. Further studies on their potential benefits (and risks) appear justified.

Abbreviations: AMP, adenosine monophosphate; CMP, cytidine monophosphate; GMP, guanosine monophosphate; IMP, inosine monophosphate; DMEM, Dulbecco’s modified Eagle’s medium; EGF, epidermal growth factor; NSAID, non-steroidal anti-inflammatory drugs; NT, nucleotides

Keywords: repair; gut growth; cell migration; injury; nutriceutical


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This Article

Services
Citing Articles
Google Scholar
PubMed
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Cardiology Jobs

Gastroenterology Jobs